Dosing completed in Phase 1 study of budoprutug subcutaneous formulation, with data expected in H1 2026 Budoprutug clinical trials ongoing in pMN, ITP, and SLE, with initial data from all three trials ...

Israel on Thursday launched a fresh wave of strikes on Iran, which stepped up its attacks on Gulf nations Qatar and Bahrain, ...

The FTSE 100 and European stocks headed lower on Thursday morning as Israel and Iran launched fresh attacks. Iran said the US ...

All eyes are on Nvidia's fourth quarter results, due after the closing bell on Wednesday, as AI concerns continue to grip markets.

Nvidia has stopped production of its second-most advanced artificial intelligence ‌chips, known as H200 chips, intended for ‌the Chinese market, the Financial Times reported on Thursday. The ​U.S.

China set its lowest economic growth target in decades on Thursday, announcing it would aim for 4.5-5% expansion in 2026 as ...

U.K. TV giant ITV on Thursday reported slightly lower earnings for its ITV Studios production unit, due to a previously highlighted change in revenue mix, and a less pronounced than expected 5 percent ...

Aviva PLC announced a 10% increase in its final dividend alongside a £350 million share buyback as it posted results for what ...

Palantir (PLTR) stock just got a major nod of approval from Wall Street. Veteran Rosenblatt Securities analyst John McPeake just raised his price target on the defense AI giant’s stock to $200 from ...

Junyang Lin, who also goes by Justin, announced on X he was stepping down as the tech lead for Qwen, Alibaba’s main AI platform. Alibaba’s shares slid as much as 5.3% in Hong Kong — their biggest ...

A massive sell-off has created a compelling entry point for this highly profitable software-as-a-service specialist.